SABBADINI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 174
EU - Europa 167
AS - Asia 99
AF - Africa 1
SA - Sud America 1
Totale 442
Nazione #
US - Stati Uniti d'America 173
SE - Svezia 110
CN - Cina 46
SG - Singapore 44
IT - Italia 21
RU - Federazione Russa 20
FI - Finlandia 5
IN - India 5
IE - Irlanda 3
DE - Germania 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
HU - Ungheria 1
MA - Marocco 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 442
Città #
New York 42
Singapore 31
Lawrence 24
Princeton 24
Shanghai 20
Boardman 19
Milan 18
Moscow 6
Helsinki 5
Ashburn 4
Dublin 3
Beijing 2
Cuddalore 2
Los Angeles 2
Mumbai 2
Pescara 2
Bengaluru 1
Bogotá 1
Bratislava 1
Dubai 1
Guangzhou 1
Hanover 1
Islamabad 1
Jinan 1
Mountain View 1
Quanzhou 1
Redwood City 1
Seattle 1
Sopron 1
Springfield 1
Stockholm 1
Warsaw 1
Xi'an 1
Zurich 1
Totale 224
Nome #
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 30
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 29
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 27
An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. 26
IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. 22
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 22
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 21
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 21
Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. 21
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. 20
Hypertension negatively affects the pregnancy outcome in patients with antiphospholipid syndrome. 20
Magnetic resonance imaging of a hypereosinophilic endocarditis with apical thrombotic obliteration in Churg-Strauss syndrome complicated with acute abdominal aortic embolic occlusion 20
Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis 19
Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. 19
Assessment of tocilizumab in the treatment of cancer cachexia 19
Pregnancy outcomes in patients with systemic autoimmunity. 18
Efficacy and toxicity of treatments for nephritis in a series of consecutive lupus patients 17
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 17
Assessment of Takayasu Arteritis Activity by Carotid Contrast-Enhanced Ultrasound 16
Ptx3 in takayasu's arteritis: an independent marker of disease activity produced at the sites of inflammation 15
Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab 12
The role of platelets in the pathogenesis of systemic sclerosis. 11
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. 11
Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. 8
Sustainability in Internal Medicine: A Year-Long Ward-Wide Observational Study 1
Totale 462
Categoria #
all - tutte 6.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 1 0
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/20228 0 0 0 8 0 0 0 0 0 0 0 0
2022/2023163 51 46 19 1 0 21 3 10 11 0 1 0
2023/2024156 2 13 15 7 14 45 1 4 0 4 18 33
2024/2025100 39 2 3 37 19 0 0 0 0 0 0 0
Totale 462